“…Then, under the combined pressures of the requirements by the pharmaceutical and fine chemicals industries for accelerated analytical throughputs and the threats of the monolithic columns that were commercialized in 2000 with great expectations, the manufacturers of packing materials capitalized on their experience in the production and packing of regular, spherical, reproducible 5 m particles [23][24][25][26][27][28] and rapidly began to commercialize columns packed with 3, then 2, and now with the sub-2 m particles, which have average sizes between 1.5 and 1.7 m. Finer particles, with average size of 1 m are already available for nearly ten years but with limited commercial success because these are solid, nonporous particles [22]. Then, a few years ago, the concept of shell particles was suddenly revived to an amazing success [29][30][31].…”